Skip to contentClarengateINTELLIGENCE
Companies/CE015600

Psoriasis UK

Charitable Incorporated Organisation

ActiveUnited KingdomIncorporated 2018Charitable Incorporated Organisation
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No electronic account filings

No extracted electronic accounts are available in our records.

Registered details

CE015600
Status
Active
Type
Charitable Incorporated Organisation
Incorporated
2018-11-13
Jurisdiction
—
Registered office
1

Classification

1 SIC codes
09999

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

5 matched grants
Optimising therapeutic strategy in psoriasis
MRC · Research Grant · 2020-02-01 – 2022-08-30 · with 7 other participants
£116,846
whole project
King'S College LondonleadBritish Association of Dermatologists (BAD)European Academy of Dermatology and VenereologyEuropean Dermatology Forum (EDF)International Psoriasis CouncilNational Institute for Health and Care ResearchThe Psoriasis AssociationUniversity Of York
Optimising therapeutic strategy in psoriasis
MRC · Research Grant · 2020-02-01 – 2022-08-30 · with 7 other participants
£116,846
whole project
King'S College LondonleadBritish Association of Dermatologists (BAD)European Academy of Dermatology and VenereologyEuropean Dermatology Forum (EDF)International Psoriasis CouncilNational Institute for Health and Care ResearchThe Psoriasis AssociationUniversity Of York
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
MRC · Research Grant · 2014-08-31 – 2021-05-30 · with 32 other participants
£5,054,543
whole project
University Of ManchesterleadAbbvieAbbVie IncAstrazenecaAstraZenecaBecton Dickinson and CompanyBecton, Dickinson and CompanyBristol-Myers SquibbBritish Association of Dermatologists (BAD)Celgene LimitedEli Lilly & Company LtdGlaxoSmithKline (GSK)GskGuy's and St Thomas' NHS Foundation TrustJanssen Pharmaceutica NVJohnson & JohnsonKing'S College LondonLEO PharmaNewcastle UniversityNHS Greater Glasgow and Clyde (NHSGGC)NovartisNovartis Pharmaceuticals UK LtdPfizerPfizer IncQiagenQiagen UKQueen Mary University of LondonRoyal College of Physicians of LondonSanquinSanquin Blood Supply FoundationThe Psoriasis AssociationUniversity College LondonUniversity of Liverpool
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
MRC · Research Grant · 2014-08-31 – 2021-05-30 · with 32 other participants
£5,054,543
whole project
University Of ManchesterleadAbbvieAbbVie IncAstrazenecaAstraZenecaBecton Dickinson and CompanyBecton, Dickinson and CompanyBristol-Myers SquibbBritish Association of Dermatologists (BAD)Celgene LimitedEli Lilly & Company LtdGlaxoSmithKline (GSK)GskGuy's and St Thomas' NHS Foundation TrustJanssen Pharmaceutica NVJohnson & JohnsonKing'S College LondonLEO PharmaNewcastle UniversityNHS Greater Glasgow and Clyde (NHSGGC)NovartisNovartis Pharmaceuticals UK LtdPfizerPfizer IncQiagenQiagen UKQueen Mary University of LondonRoyal College of Physicians of LondonSanquinSanquin Blood Supply FoundationThe Psoriasis AssociationUniversity College LondonUniversity of Liverpool
Consortium Building
MRC · Research Grant · 2012-09-30 – 2013-03-31 · with 21 other participants
£20,000
whole project
University Of ManchesterleadAbbVie IncAstrazenecaBecton, Dickinson and CompanyBristol-Myers SquibbBritish Association of Dermatologists (BAD)Eli Lilly & Company LtdGlaxoSmithKline (GSK)Guy's and St Thomas' NHS Foundation TrustJohnson & JohnsonKing'S College LondonLEO PharmaNewcastle UniversityNHS Greater Glasgow and Clyde (NHSGGC)NovartisPfizer IncQiagenQueen Mary University of LondonRoyal College of Physicians of LondonSanquinThe Psoriasis AssociationUniversity of Liverpool